Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Irbesartan on Oxidative Stress and C-Reactive Protein Levels in Patients With Persistent Atrial Fibrillation

NCT00613496 is registered in ClinicalTrials.gov with University of Magdeburg as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT00613496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Irbesartan on Oxidative Stress and C-Reactive Protein Levels in Patients With Persistent Atrial Fibrillation
Lead sponsor
University of Magdeburg
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2009
Completion date
May 31, 2010
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation

Lead sponsor's other trials

University of Magdeburg, most recent start first.

Similar trials

Same condition (Atrial Fibrillation) and phase, most recent start first.